Skip to main content
. 2017 Oct 19;61(3):222–227. doi: 10.3164/jcbn.17-57

Table 2.

Hazard ratios of impaired liver function in patients after TACE or HAIC

Hazard ratio 95%CI p value
BCLC (intermediate or advanced) 12.7 3.32–84.29 <0.001
Dose of cislatin (mg/body) 1.01 0.99–1.03 0.372
Treatment without NK1 antagonist 3.36 1.14–10.23 0.002